The board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited announced the following change of independent non-executive director of the Company ("Independent Non-executive Director") and composition of the board committees of the Company with effect from 13 March 2023: Mr. Zhao Zhong Zhen ("Mr. Zhao") has tendered his resignation to the Board as an Independent Non-executive Director due to other business commitment and personal endeavours. As a result, Mr. Zhao ceased to be the chairman of the remuneration committee of the Company, a member of each of the audit committee, nomination committee and competition supervisory committee of the Company. Mr. Zhao has confirmed that he has no disagreement with the Board or the Company and there is no matter in relation to his resignation that needs to be brought to the attention of shareholders of the Company (the "Shareholders") or The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). Mr. Xu Hong Xi ("Mr. Xu") has been appointed as an Independent Non-executive Director, the chairman of the remuneration committee of the Company, a member of each of the audit committee, nomination committee and competition supervisory committee of the Company. Xu Hong Xi, aged 61, is currently the chief professor of Shanghai University of Traditional Chinese
Medicine, the honorary dean of the School of Pharmacy and the head of Shanghai College Engineering Research Center for Innovative Pharmaceutical Research and Development of Chinese Medicine. Mr. Xu serves as a distinguished professor of Organization Department of the Central Committee of the Chinese Communist Party, the first batch "Shanghai Distinguished Expert" and concurrently serves as the secretary-general of Chinese Medicine Academic Disciplinary Assessment team of the State Council Academic Degrees Committee, a member of Chinese Medicine Professional Education Steering Committee under Ministry of Education, a member of Chinese Pharmacopoeia Commission, the chairman of Chinese Medicine Experimental Pharmacology Branch of China Association of Chinese Medicine, the chairman of Chinese Medicine Professional Committee of Shanghai Pharmaceutical Association, the co-chairman of International Conference of the Modernization of Chinese Medicine. Mr. Xu successively served as the scientific officer of Chinese Medicine Research Centre at the Chinese University of Hong Kong, the deputy general manager and senior medical advisor of Hutchison Whampoa (China) Limited, a director and the R & D director of Shanghai Hutchison Pharmaceuticals Limited, and the deputy director of Hong Kong Jockey Club Institute of Chinese Medicine. Mr. Xu graduated from Shanghai University of Traditional Chinese Medicine in 1983 and 1989 with a bachelor's degree and master's degree, respectively, and obtained his Ph.D. degree in Pharmaceutical Sciences in 1994 from Toyama Medical and Pharmaceutical University in Japan, and conducted postdoctoral research in National University of Singapore and Dalhousie University in Canada between 1994 and 1998. The Board further announces that Ms. Feng Li ("Ms. Feng"), currently an executive director of the Company ("Executive Director"), has been re-designated as a non-executive director of the Company ("Non-executive Director") with effect from 13 March 2023 due to other business commitment. Feng Li, aged 47, was appointed as an Executive Director on 12 August 2022. Ms. Feng currently serves as a non-executive director of Tong Ren Tang Technologies Co. Ltd. (a company listed on the Stock Exchange, stock code: 1666), a controlling Shareholder ("Controlling Shareholder", as defined in the Listing Rules) of the Company, and the deputy general manager and the secretary to the board of directors of Beijing Tong Ren Tang Company Limited (a company listed on the Shanghai Stock Exchange, stock code: 600085), a Controlling Shareholder. Ms. Feng joined Beijing Tong Ren Tang Group in March 2012 and was formerly served as the manager of the Internal Audit and Legal Department, the assistant to the general manager and the manager of the Economic Operation Department of the Company. Prior to joining Beijing Tong Ren Tang Group, Ms. Feng worked as a senior audit manager at PricewaterhouseCoopers Zhongtian LLP. Ms. Feng graduated from the Department of International Economics of Peking University in 1998 with a bachelor's degree in economics and she is also a certified
public accountant in China (non-practicing).